n,n-dimethylarginine has been researched along with Hyperuricemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, Y; Fukae, S; Ikeda, S; Kawano, H; Koga, S; Maemura, K; Minami, T; Nakata, T; Tsuneto, A; Yonekura, T | 1 |
| Chen, CH; Guo, BC; Hsu, CP; Lee, TS; Lu, TM | 1 |
| Leonardis, D; Mallamaci, F; Pisano, A; Sanguedolce, MC; Spoto, B; Testa, A; Tripepi, G; Zoccali, C | 1 |
| Abe, T; Toyohara, T | 1 |
1 review(s) available for n,n-dimethylarginine and Hyperuricemia
| Article | Year |
|---|---|
[Analysis of transporter function and development to clinical application].
Topics: Aconitic Acid; Animals; Arginine; Guanidines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperuricemia; Kidney; Organic Anion Transporters; Organic Cation Transport Proteins; Rats; Renal Insufficiency; Succinates | 2011 |
1 trial(s) available for n,n-dimethylarginine and Hyperuricemia
| Article | Year |
|---|---|
Randomized, Open-Label, Cross-Over Comparison of the Effects of Benzbromarone and Febuxostat on Endothelial Function in Patients with Hyperuricemia.
Topics: Adiponectin; Aged; Arginine; Benzbromarone; Cross-Over Studies; Endothelium, Vascular; Febuxostat; Female; Gout Suppressants; Humans; Hyperemia; Hyperuricemia; Male; Middle Aged; Organic Anion Transporters; Organic Cation Transport Proteins; Treatment Outcome; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 2020 |
2 other study(ies) available for n,n-dimethylarginine and Hyperuricemia
| Article | Year |
|---|---|
Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway.
Topics: Amidohydrolases; Animals; Arginine; Atherosclerosis; Endothelial Cells; Humans; Hyperuricemia; Mice; Nitric Oxide | 2021 |
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.
Topics: Aged; Alleles; Arginine; C-Reactive Protein; Calcium; Case-Control Studies; Cohort Studies; Creatinine; Disease Progression; Endpoint Determination; Female; Follow-Up Studies; Genetic Markers; Glucose Transport Proteins, Facilitative; Hemoglobins; Humans; Hyperuricemia; Male; Middle Aged; Nitric Oxide Synthase; Polymorphism, Single Nucleotide; Proportional Hazards Models; Renal Insufficiency, Chronic; Serum Albumin; Uric Acid | 2015 |